Alexandru Stieber/LinkedIn
Dec 1, 2025, 15:32
Alexandru Stieber on a Curious Finding: GLP-1 RAs and the Risk of Optic Neuropathy
Alexandru Stieber, Internal Medicine Resident at SUUMC Bucharest, posted on LinkedIn:
“A very curious research revealing a possible link between the use of GLP-1 receptor antagonists such as semaglutide or liraglutide and the risk of developing nonarteritic ischemic anterior optic neuropathy, current findings which support previous studies on the matter and that nuance the uses of such therapeutic agents.”
Title: GLP-1 RAs and Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Older Patients With Diabetes
Authors: Kin Wah Fung, Fitsum Baye, Seo H. Baik, Clement J. McDonald
Read full article here.
Stay updated with Hemostasis Today.
-
Jan 16, 2026, 06:05Wolfgang Miesbach on Jacob Lund’s Study: How to Define FVIII Bioequivalence
-
Jan 16, 2026, 05:52Piotr Czempik Shares His Latest Contribution to Acta Haematologica Polonic
-
Jan 16, 2026, 05:44Florian Piekarski on Perioperative Blood Management When Allogeneic Transfusion is Not Aaccepted
-
Jan 16, 2026, 05:00Plaque Rupture and Thrombosis
-
Jan 16, 2026, 04:52Arterial Disease Across Vascular Beds․ Lipoprotein(a) as a Causal Risk Factor
-
Jan 16, 2026, 04:51Higher-Dose Clotting Factor Prophylaxis Does Not Reduce Postpartum Hemorrhage in Women with von Willebrand Disease
-
Jan 16, 2026, 04:48Reza Shojaei on Plasma Donation as Life-Changing Medicine in Motion
-
Jan 16, 2026, 04:11Open-Label Extension Study of Marstacimab: Pfizer Has Reported a Fatal Event
-
Jan 16, 2026, 04:11Why is DVT More Common In the Left Leg? Dr Raheel Moazzam’s New Study Gives Answers!